DDrare: Database of Drug Development for Rare Diseases

Searched query = "Huge lymphatic malformation with cervicofacial lesion", "Huge lymphatic malformation", "Lymphatic malformation"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Drug = Bleomycin; Device: MRI; Indocyanine green; L04AA10; OK432; Picibanil; Propranolol; RAPAMUNE; Rapamune; Rapamycin; Rapamycin dosage; SIROLIMUS; Selenium; Sildenafil; Sildenafil 20 mg tablets; Sirolimus; Sirolimus 0,1% crème; Sirolimus 1mg/mL; Sirolimus Oral Liquid Product 1mg/mL; Topical 0.1% Sirolimus; Topical Vehicle; VT30; Water

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04128722 (ClinicalTrials.gov)	February 14, 2020	24/9/2019	TOPical Sirolimus in linGUal Microcystic Lymphatic Malformation -TOPGUN	TOPical Sirolimus in linGUal Microcystic Lymphatic Malformation -TOPGUN	Lingual Microcystic Lymphatic Malformations	Drug: Sirolimus Oral Liquid Product 1mg/mL	University Hospital, Tours	NULL	Recruiting	5 Years	N/A	All	12	Phase 2	France

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT04128722
(ClinicalTrials.gov)

February 14, 2020

24/9/2019

TOPical Sirolimus in linGUal Microcystic Lymphatic Malformation -TOPGUN

Lingual Microcystic Lymphatic Malformations

Drug: Sirolimus Oral Liquid Product 1mg/mL

University Hospital, Tours

NULL

Recruiting

5 Years

N/A

All

Phase 2

France